Project Grant R01AI199268
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $137,064 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 25, 2025. The two-year project, concluding June 30, 2027, delivers novel conceptual frameworks and computational models to measure and validate dynamic accessibility to healthcare using system science approaches. The primary...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a $422,125 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective February 3, 2026, with a completion date of January 31, 2028. This proof-of-concept study will develop, validate, and field-test wastewater-based epidemiology (WBE) methods using digital polymerase chain reaction (PCR) to detect Shigella species in wastewater as a...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a $502,248 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective June 6, 2025, with completion targeted for May 31, 2030. This research initiative focuses on investigating the STING (Stimulator of Interferon Genes) pathway's role in protecting human intestinal epithelial cells from rotavirus infection. The project will...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Indiana University a $503,887 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop innovative therapeutic strategies targeting Vibrio bacterial infections. The award, dated September 1, 2025, with an ultimate completion date of August 31, 2026, funds research directed by co-principal investigators Dr. Jon Paczkowski and Dr. Julia Van Kessel to advance...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a $1,348,845 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 13, 2026, with a completion date of January 31, 2031. The research investigates how potassium (K+) efflux through ATP-gated inward rectifier potassium (KATP) channels regulates antiviral immune responses and reduces viral replication across diverse organisms...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida's Division of Sponsored Research a Project Grant of $135,107 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 20, 2025, with a completion date of May 31, 2027. This project develops and optimizes micro-computed tomography (micro-CT) imaging protocols to quantify mosquito blood-feeding rates, a critical metric for assessing...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $812,427 Project Grant on August 1, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, San Diego to develop an HIV Molecular Epidemiology (ME) Dashboard for identifying HIV transmission patterns and prevention gaps in Florida. The primary deliverable is an interactive online dashboard integrating de-identified and aggregated HIV...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a Project Grant of $610,971 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, with a completion date of January 31, 2031. This research award supports a comprehensive investigation into the role of the host ubiquitin ligase CUL4B in gammaherpesvirus latency and lymphoma development, utilizing the mouse gammaherpesvirus...
- Federal Grant Award Summary The University of Florida Division of Sponsored Research received a $424,223 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 10, 2025, with completion anticipated by May 31, 2027. This award supports biomedical research investigating lipid-gene molecular profiles in sepsis-induced acute respiratory distress syndrome (ARDS). The research...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $402,150 Project Grant award dated July 23, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research award, with a completion date of June 30, 2027, supports investigator-initiated biomedical research focused on understanding the viral mechanisms by which Kaposi's Sarcoma-Associated Herpesvirus...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a $741,023 Project Grant, effective June 1, 2026 through May 31, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant funds development of VIGOR (Vibrio Infection Genomics for Outbreak Risk Forecasting), a satellite-based public health forecasting system designed to identify and monitor high-risk zones for pathogenic Vibrio species proliferation in coastal waters. The research will integrate biweekly field sampling, high-throughput genomic sequencing, satellite remote sensing, and machine learning-based pathogen modeling to detect and characterize pathogenic Vibrio bacteria in coastal microbiomes and determine the impact of severe weather events and geophysical parameters on their prevalence and diversity. The primary deliverables include: (1) genomic characterization of pathogenic Vibrio species using molecular and sequencing tools; (2) validated ecological niche models employing MaxEnt architecture to forecast seasonal and spatial hotspots of Vibrio risk; and (3) a real-time public health information dissemination platform that overlays environmental, microbial, demographic, and infrastructural vulnerability data for early detection and targeted public health interventions. This research addresses the growing threat of Vibrio-associated infections in coastal regions, with particular relevance to Florida's high incidence of vibriosis linked to hurricanes and harmful algal blooms, and aims to reduce the burden of waterborne infections through predictive epidemiological forecasting.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $741.0k | 6/3/26 |